Seize new opportunities for the development of metropolitan areas to make established enterprises glow with new vitality
Release time:
2020-07-31
Zhejiang Jianfeng Group Co., Ltd. is an old enterprise in Jinhua. It has a history of years since the first generation of Jianfeng people founded Jinhua Cement Factory in 1958 . From the initial small cement plant to the current cement, medicine, health products, warehousing and logistics as a supplement, cross-industry, cross-regional comprehensive enterprise group, the peak has embarked on its own development path.
In the past two years, affected by the downward pressure of the economy, some companies have been in trouble, but the spikes have bucked the trend, and good news has spread frequently. In the past five years, the average annual profit of the peak has exceeded 2.5 billion yuan, and the total profit and tax paid has been 8.27 .2 billion yuan. In the past year of 2016 , operating income 23.79 .6 billion and net profit 2.85 .8 billion created the best results in peak history. Net profit 1.12 .2 billion yuan in the first quarter report of 2017 , once again setting a new quarterly performance record.
Under the background of "walking in the forefront and building Jinhua together", this year, the Jinhua Municipal Party Committee and the Municipal Government also proposed to vigorously promote the comprehensive transportation corridor, Jinyi Kechuang Corridor, and the ecological corridor in central Zhejiang. The strategic deployment of "three corridors construction" has drawn a new blueprint for Jinhua's future economic and social development. In the face of new opportunities, Jiang Xiaomeng, chairman of Jianfeng Group, said that as the fourth largest metropolitan area in the province, the construction of Jinhua's "three corridors" will certainly have a positive and far-reaching impact on the trend of related industries and the positioning of enterprises in central Zhejiang. The majority of business operators and businessmen should actively participate in the new wave of reform and development, and seriously think about how to combine the construction needs of the "three corridors", give play to play to the enterprise itself, so as to catch the "big car" of Jinhua's economic development, while promoting local economic development, enable enterprises to grow better and faster.
Stick to Industry Unshakable, Five Aspects "Stick to" Re-innovate Performance
# For more than 31 years, Jianfeng Group has been sticking to Industry. This has also become an iron law for the development of the peak industry. 1993 7 28 , Jianfeng Group's shares were successfully listed on the Shanghai Stock Exchange, becoming the first listed company in the national cement industry. After years of exploration and integration of 20 , the peak finally formed a business pattern with cement and medicine as the main industry and health products, international trade and warehousing and logistics as the supplement.
Today's peak, from cement, medicine to warehousing, logistics, the system is more perfect. In the face of the achievements made in the past few years, Jiang Xiaomeng, chairman of Jianfeng Group, said that it was the land of Jinhua that nurtured the growth of Jianfeng, and striving to do a good job in the enterprise is the best return to Jinhua. He said, "Spike has been doing industry for more than 50 years and will not leave industry in the future".
Cement and medicine are all fully competitive industries. Why can an old company achieve such good new results? Jiang Xiaomeng believes that in addition to continuously strengthening the adjustment of its own industrial structure in accordance with the changes in the economic environment, the sound development of the peak in recent years has benefited from the persistence of five aspects: adhere to the development strategy of "cooperative innovation to strengthen the main business, standardize science and seek development"; adhere to accurate market positioning according to its own reality, that is, leading the cost of cement and being a niche in the regional market, it is a leading enterprise in pharmaceutical technology, a leading enterprise in product market segmentation, a leader in health product industry with natural raw materials and innovation in health products. Established a control system of "strict budget effective authorization" and insisted on implementing it. It has a management team that is united and pragmatic, pioneering and innovative, has a reasonable age composition and a solid and comprehensive knowledge structure. After several generations of peak people continuously refined and enriched, A corporate culture that meets the needs of peak reality and development has been formed.
Enterprise development is pragmatic, energy conservation and environmental protection at all costs to invest
as a leading enterprise at the same level in Jinhua City, what will be the "action" of the sharp peak group for the construction of "three corridors"? Faced with this problem, Jiang Xiaomeng said, the peak in recent years has been doing industrial restructuring, in fact, and Jinhua "three corridors" overall construction framework fit.
In terms of ecological development, as early as ten years ago, Jianfeng has consciously transferred the high-pollution and high-emission cement industry to other places, using local resource advantages and market advantages to vigorously promote environmental protection and energy-saving transformation such as waste heat power generation, desulfurization and denitration while making profits, thus successfully realizing the upgrading of traditional industries. Based on Jinhua's Jianfeng Pharmaceutical Industry, the Jinxi production base with an investment of 5.8 .8 billion yuan has been fully put into operation in 2015 . From the beginning of the design, it has set high standards for energy conservation, emission reduction and comprehensive utilization of resources. Peak Health, a new enterprise, uses natural plants as raw materials to produce and sell health products, and has already made a lot of investment in the construction of ecological raw material bases, emission reduction and environmental protection.
Among them, in terms of environmental protection construction, Peak will continue to invest 3 million yuan in the next three years to carry out emission rectification.
In terms of transportation and logistics, the board of directors of Jianfeng Group held recently passed a resolution to invest million yuan in jindong district to build a modern e-commerce park, which is beneficial and complementary to Jianfeng's original bonded storage, logistics, futures delivery and other businesses. In addition, the construction of traffic corridors is bound to have a large number of engineering construction, which will also bring new development opportunities to the cement building materials industry. The new strategy of
focuses on the future. Scientific and technological innovation promotes the transformation and upgrading of enterprises
. In terms of scientific and technological innovation, Jianfeng Pharmaceutical has established the research and development idea of "42 ", which takes anti-infective drugs, cardiovascular and cerebrovascular drugs, drugs for elderly children and anti-tumor drugs as the main line, antidepressant drugs and eye drops as supplements, and enters the field of biological agents in due course, extensive and in-depth cooperation with relevant universities and research institutes.
If Professor Wang Guangji, an academician of the Chinese Academy of Engineering, is hired as the chief scientist, the national first-class anti-tumor new drug being developed by his scientific research team has been included in the national major innovation plan this year; Sichuan Antibiotic Research Institute, which has been cooperating with Jianfeng for many years, is currently planning to establish a branch in Jinhua, further cooperation with Spike Pharmaceuticals in product, business and technical exchanges... These will lay a good foundation for Spike Pharmaceuticals to upgrade its products and expand its industry.
In addition to the above aspects, Jianfeng will invest more than million yuan in the near future to upgrade the original drug production line to the US and EU standard GMP to create basic conditions for preparation products to go abroad. Guangxi Huibaoyuan Pharmaceutical Technology Company, which has recently participated in the reorganization, has introduced experts and technologies from Yale University in the United States to conduct innovative research and development and production; in Jinhua's pharmaceutical enterprises, the current planned investment in product research and development has reached 1.5 billion yuan. Jiang Xiaomeng said that the provincial government and the municipal government recently issued support policies to reduce corporate taxes, which provided new assistance for enterprises to participate in the construction of the "three corridors. Jinhua's enterprises and entrepreneurs should seize this favorable opportunity to participate in the construction of the "three corridors" and contribute to Jinhua's economic and social development. (Zhejiang News Client Reporter Qian Key )
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31